Search
Search Results
- Publication:
- Washington Post Company, 26 May 1977
- Subject(s):
- Myocardial Infarction
United States Food and Drug Administration
Legislation, Drug
- Archival Collection:
- The Mary Lasker Papers (Profiles in Science)
- Publication:
- Washington Post Company, 16 September 1968
- Subject(s):
- Heart Diseases
Legislation, Drug
- Archival Collection:
- The Mary Lasker Papers (Profiles in Science)
- Author(s):
- Waxman, Henry, author
Corr, Bill, author
Martin, Kristi, author
Duong, Sophia, author
- Publication:
- [New York, N.Y.] : Commonwealth Fund, July 2017
- Subject(s):
- Cost Control
Drug Costs
Health Policy
Prescription Drugs -- economics
Drug Industry -- economics
Drugs, Generic -- economics
Economic Competition
Legislation, Drug
Orphan Drug Production -- economics
Humans
United States
- Author(s):
- White, Robert S., (Compliance attorney and member of the Oklahoma Bar), author
- Publication:
- [Toronto, Ontario] : Thomson Reuters, 19-December-2022
- Subject(s):
- Drug Approval -- legislation & jurisprudence
Government Regulation
Legislation, Drug
Drug-Related Side Effects and Adverse Reactions
Illicit Drugs
United States
United States. Food and Drug Administration
- Author(s):
- Purvis, Leigh, author
McSpadden, James, author
- Publication:
- Washington, DC : AARP Public Policy Institute, October 2022
- Subject(s):
- Biosimilar Pharmaceuticals
Cost Savings
Health Services Accessibility
Legislation, Drug
Drug Costs
State Government
United States
- Author(s):
- Purvis, Leigh, author
- Publication:
- Washington, D.C. : AARP Public Policy Institute, September 2014
- Subject(s):
- Biological Products -- economics
Biological Products -- therapeutic use
Biosimilar Pharmaceuticals -- economics
Biosimilar Pharmaceuticals -- therapeutic use
Drug Costs
Drug Substitution
Legislation, Drug
Drugs, Generic -- economics
Federal Government
State Government
Humans
United States
United States. Food and Drug Administration.
United States.
- Author(s):
- Steiner, David J., author
- Publication:
- [Toronto, Ontario] : Thomson Reuters, 20-December-2021
- Subject(s):
- Cost Savings
Drug Costs -- legislation & jurisprudence
Legislation, Drug
Prescription Drugs -- economics
State Government
United States
- Author(s):
- Steiner, David J., author
- Publication:
- [Toronto, Ontario] : Thomson Reuters, 23-December-2019
- Subject(s):
- Cost Control -- legislation & jurisprudence
Cost Savings
Drug Costs -- legislation & jurisprudence
Economics, Pharmaceutical
Legislation, Drug
Access to Information
Biosimilar Pharmaceuticals
Commerce
Conflict of Interest
Drug Industry
Insurance, Pharmaceutical Services
Managed Care Programs
Medicaid -- economics
Medicare Part D -- economics
Patents as Topic
State Government
Humans
United States
- Author(s):
- Steiner, David J., author
- Publication:
- [Toronto, Ontario] : Thomson Reuters, 23-December-2019
- Subject(s):
- Drug Costs
Medicare Part D -- economics
Medicare Part D -- legislation & jurisprudence
Biosimilar Pharmaceuticals -- economics
Cost Control -- legislation & jurisprudence
Drugs, Generic -- economics
Economics, Pharmaceutical
Financing, Personal
Fraud
Legislation, Drug
Medicare Part C
Opioid-Related Disorders
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)
- Author(s):
- Steiner, David J., author
- Publication:
- Toronto, Ontario : Thomson Reuters, 23-December-2019
- Subject(s):
- Commerce
Drug Industry -- legislation & jurisprudence
Equipment and Supplies
Legislation, Drug
Analgesics, Opioid
Crime
Equipment Failure
Equipment Safety
Federal Government
Fraud
Medical Device Recalls
Opioid-Related Disorders -- epidemiology
Patents as Topic
Prescription Drug Diversion
Humans
United States
